🇺🇸 FDA
Patent

US 11174292

Substitutions-modified prefusion RSV F proteins and their use

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 11174292 (Substitutions-modified prefusion RSV F proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/53, A61K2039/543